Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

This article originally published with the family name and given names of all authors transposed.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7852861PMC
http://dx.doi.org/10.1007/s10067-020-05410-yDOI Listing

Publication Analysis

Top Keywords

correction efficacy
4
efficacy safety
4
safety randomized
4
randomized double-blind
4
double-blind study
4
study comparing
4
comparing proposed
4
proposed biosimilar
4
biosimilar abp
4
abp 798
4

Similar Publications

Purpose: To study the efficacy and safety of pro re nata regimen of brolucizumab, without loading dose, in treatment-naive patients with neovascular age-related macular degeneration (nAMD).

Case Series: Retrospective, observational study. We included all consecutive patients diagnosed with treatment- naïve nAMD undergoing Brolucizumab in Humanitas eye clinic, Turin, Italy between April 2022 and May 2023.

View Article and Find Full Text PDF

Aim: The objective of this study was to evaluate the efficacy of DIMS (Defocus Incorporated Multiple Segments) in comparison to control group (CTRL) in a wide age group of European progressive myopes (6-26 years).

Methods: In this prospective, non-randomised observational study, 78 myopes with progression myopia to -0.25 to -8.

View Article and Find Full Text PDF

Background: Presently, the availability of single-stage surgical correction of mitral valve disease combined with atrial fibrillation (AF) via a mini-access approach remains limited. Moreover, the comparative effectiveness of this procedure versus conventional sternotomy (CS) remains poorly understood. Thus, this study aimed to conduct a comparative assessment of the efficacy and safety of concomitant mitral valve surgery and AF ablation via a minimally invasive approach (minimally invasive cardiac surgery, MICS group) versus the standard sternotomy approach (CS group).

View Article and Find Full Text PDF